SKAN Group's First Capital Market Day Highlights Strategic Growth

SKAN Group has hosted its inaugural Capital Market Day in Allschwil, offering investors and analysts insights into its growth strategy. Attendees learned about the isolator market's drivers, including demographic changes and biotechnology advances. SKAN also highlighted its market leadership, technological edge, and extensive service network as key competitive advantages.

The Group's strategy centers on reinforcing its market leadership and expanding its service offerings. Emphasis was placed on increasing standardization, enhancing efficiency, and deepening regulatory knowledge. Another significant focus is the digital transformation and strengthening SKAN's unique corporate culture.

Mid-term targets indicate net sales growth in the mid to upper teens, with a higher growth rate expected for Services & Consumables than Equipment & Solutions. The anticipated expansion of the EBITDA margin is also part of these targets.

A tour of the new Pre-Approved Services facility was a key event, showcasing SKAN's commitment to competitive advantage by speeding up the drug market entry for clients.